Altitude Sickness
Recent clinical, regulatory, research and industry developments relating to this disease.
Changes in immune cell populations during acclimatization to high altitude.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes4
- Acclimatization1
- Altitude1
- Altitude Sickness1
- Leukocytes, Mononuclear1
Leading journals1
- Physiological reports1
Leading researchers5
- Frost S1
- Heinrich EC1
- Pham K1
- Shah S1
- Vargas A1
Affiliations (unnormalised)1
- School of Medicine1
Associated genes
Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.
Disease biology
Proteins whose encoding gene is associated with this disease, reached through the canonical gene→disease graph. Number shows the gene's association score.
Reference
Authoritative identity, definition & identifiers.
Multiple symptoms associated with reduced oxygen at high ALTITUDE.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.